ADXN Q1 2024 Earnings Biotech Reports Net Loss Amid Clinical Pipeline Progress FNLC Q1 2026 Earnings Solid EPS Performance Amidst Quiet Market Reaction VSEC Q1 2026 Earnings EPS Surges 2776 Above Estimates Amid Operational Strength RRC Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency and Cost Controls IO Biotech Q3 2025 Earnings EPS Beats Estimates by 6067 as Narrowing Losses Highlight Cost Discipline SLG Q1 2026 Earnings EPS Misses Amid Market Volatility Stock Rises on Operational Resilience